TrialCancer chemotherapy and pharmacology2014

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors.

Woondong Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.